Free Beta: Procurement discovery is free; verify every opportunity on SAM.gov. Source status
OtherClosing soon

Frozen Blood Bags

DEPT OF DEFENSE › DEFENSE HEALTH AGENCY (DHA) › DEFENSE HEALTH AGENCY

Response deadlineSep 1, 2026 10:00 AM EDT
View official notice on SAM.gov (opens in a new tab)
Verify before acting. Users must verify deadlines, amendments, attachments, eligibility, and submission requirements on the official SAM.gov notice. Read the Data Disclaimer.

Key decision factors

Response deadline
Sep 1, 2026 10:00 AM EDT
Posted
Aug 27, 2026 12:00 AM EDT
Notice type
Special Notice
Set-aside
No Set aside used
NAICS
339112
PSC
6515
Place of performance
Camp Lejeune, North Carolina
Current status
Closing soon

Notice details

Official status
Closing soon
Normalized group
Other
Notice ID
374ee73aa4684306b1e3d014345e6d85
Solicitation number
Not provided by SAM.gov

Description

Displayed as sanitized plain text from SAM.gov. Retrieved Aug 28, 2026 5:16 PM EDT.

This Notice of Intent is not a request for competitive proposals. This is not a solicitation or request for offers. No solicitation package is available, and telephone requests will not be honored. Only one responsible source, and no other supplies or services will satisfy agency requirements. The Defense Health Agency Contracting Activity (DHACA) Healthcare Contracting Division- Southeast (HCD-Southeast) is issuing this Notice of Intent (NOI) to inform industry contractors of the Government’s intent to execute a Sole Source contract under FAR 6.103-1, Only one responsible source and no other supplies or services will satisfy agency requirements. This notice satisfies posting requirements at FAR Part 5.101. The proposed source is Fenwal, Inc., a Fresenius Kabi Company (Fenwal) of Three Corporate Drive, Lake Zurich, IL 60047. The Naval Medical Center Camp Lejeune (NMCCL), NC Blood Donor Center has a requirement for CPDA triple blood bags and Glycerolyte 57% Solution. The requested items shall be configured and validated for use with the Haemonetic ACP 215s that NMCCL currently owns. The items shall be Food and Drug Administration (FDA) approved for patient care. The requested supplies shall be configured and validated for use with the AMICUS™ Separator Collection System that NMCCL currently owns. The supplies shall be delivered timely, and products shall be free of defects in accordance with federal and industry standards per Food and Drug Administration (FDA) regulations. The supplies shall be provided for a delivery period from 01 October 2026 – 30 September 2027. There are no set-aside restrictions for this requirement. The intended procurement will be classified under North America Industry Classification System (NAICS) 339112- Surgical and Medical Instrument Manufacturing. The Product/Service Code (PSC): 6515- Medical and surgical instruments, equipment, and supplies. The Small Business Administration (SBA) size standard is 1,000 employees. Parties interested in responding to this notice will need to submit technical data sufficient to determine capability in providing the same supplies or services. All capability statements received by the closing date of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. If a vendor challenges the basis of this requirement, please email product capability statements (formats for submission: PDF or MS Word, shall not exceed 3 (8.5 x 11 inch) pages using a font size no smaller than 11-point.) to Koffi Alognon at koffi.e.alognon.civ@health.mil . Closing date for challenges is no later than 10:00 AM ET on Tuesday, 01 September 2026. No phone calls will be accepted.

Contacts

Koffi Alognon
Primary
koffi.e.alognon.civ@health.mil

Personalized relevance

Would this fit your company?

Create company profile information with a free account to see a deterministic, explainable relevance score. Matching does not determine eligibility or win probability.

Create Free Account

Pursuit risk (separate from your match score)

Strong pursuit warning

This notice contains language indicating a sole-source or otherwise restricted procurement. Review the cited evidence before investing time in a response.

Detected in

  • Description“ies or services will satisfy agency requirements. The Defense Health Agency Contracting Activity (DHACA) Healthcare Contracting Division- Southeast (HCD-Southeast) is issuing this Notice of Intent (NOI) to inform industr”
  • Description“on- Southeast (HCD-Southeast) is issuing this Notice of Intent (NOI) to inform industry contractors of the Government’s intent to execute a Sole Source contract under FAR 6.103-1, Only one responsible source and no other”

Pursuit risk is evaluated separately from your match score above and never changes it. This is not a legal or eligibility determination — verify against the official SAM.gov notice and attachments.